MTA1: Difference between revisions
CSV import |
CSV import |
||
| Line 32: | Line 32: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 18:16, 17 March 2025
MTA1 or Metastasis Associated 1 is a protein that in humans is encoded by the MTA1 gene. It is a part of the nuclear receptor co-repressor complex and plays a significant role in gene expression and cellular differentiation, proliferation, and apoptosis.
Function[edit]
MTA1 is a component of the NuRD, a multisubunit complex which couples histone deacetylase activity and nucleosome remodeling activity. The protein encoded by this gene is thought to play a role in the regulation of transcription and is known to be a potent suppressor of metastasis.
Clinical significance[edit]
MTA1 has been found to be upregulated in a number of cancer types, including breast cancer, prostate cancer, and colorectal cancer. Its overexpression has been linked to increased metastatic potential and poor prognosis in these cancers.
Research[edit]
Research into MTA1 is ongoing, with studies focusing on its role in cancer progression and potential as a target for cancer therapy.
See also[edit]
References[edit]
<references />
